|
JP2010111706A
|
|
Bone resorption inhibitor including interleukin-6 receptor antibody as active ingredient
|
|
JP2006213737A
|
|
Bone resorption inhibitor including interleukin-6 receptor antibody as active ingredient
|
|
JP2004224801A
|
|
Therapeutic agent for disease caused by il-6 production
|
|
JP2001269186A
|
|
Il-6 receptor derivative
|
|
JPH10309148A
|
|
Transgenic animal lacking in osteogenesis function
|
|
JPH09104629A
|
|
Leukemia cell proliferation inhibiting agent containing antisense oligonucelotide derivative against wilms tumor gene (wt1)
|
|
JPH08228786A
|
|
Production of human bcdf
|
|
JPH08169846A
|
|
Therapeutic agent for disease due to il-6 production
|
|
JPH07324096A
|
|
Transcript aprf
|
|
JPH07165608A
|
|
Bone absorption inhibitor comprising interleukin 6 receptor antibody as active ingredient
|
|
JPH07188056A
|
|
Suppressor for bone resorption containing antibody against interleukin 6 receptor as active ingredient
|
|
JPH05192152A
|
|
Nf-il6beta gene
|
|
JPH0591892A
|
|
Il-6 receptor derivative
|
|
JPH05211888A
|
|
Antibody to murine interleukin-6 receptor and its use
|
|
JPH03184997A
|
|
B cell differentiating factor
|
|
JPH04190796A
|
|
Mouse gp130 protein
|
|
JPH04187645A
|
|
Agent for suppressing action of interleukin 6
|
|
JPH04169538A
|
|
Interleukin-6 acting inhibitor
|
|
JPH03236782A
|
|
C/ebp2 gene and recombinant c/ebp2
|
|
JPH0499800A
|
|
Production of recombinant mouse il-6 receptor
|
